Calcium-activated potassium channel activator down-regulated the expression of tight junction protein in brain tumor model in rats

Neuroscience Letters

Volumn 493, Issue 3, 2011, Pages 140-144

  Gu, Yan Ting ^a   Xue, Yi Xue ^b   Wei, Xiu Yan ^a   Zhang, Hua ^b   Li, Yan ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Blood tumor barrier; Calcium activated potassium channel; Glioma; Reactive oxygen species; Tight junction

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; MALONALDEHYDE; MESSENGER RNA; OCCLUDIN; PROTEIN ZO1; REACTIVE OXYGEN METABOLITE; TIOPRONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CONTROLLED STUDY; DOWN REGULATION; GLIOMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIGHT JUNCTION; WESTERN BLOTTING;

ANIMALS; BENZIMIDAZOLES; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CELL MEMBRANE PERMEABILITY; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GLIOMA; MALE; MEMBRANE PROTEINS; PHOSPHOPROTEINS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; TIGHT JUNCTIONS;

EID: 79952899548     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.02.029     Document Type: Article

References (22)

1. Drappatz J., Schiff D., Kesari S., Norden A.D., Wen P.Y. Medical management of brain tumor patients. Neurol. Clin. 2007, 25:1035-1071.
2. Hayashi Y., Yoshida Y., Hamada J. Blood-tumor barrier in malignant brain tumor. No Shinkei Geka 2006, 34:983-999.
3. Ningaraj N.S., Rao M., Hashizume K., Asotra K., Black K.L. Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels. J. Pharmacol. Exp. Ther. 2002, 301:838-851.
4. Komarova Y., Malik A.B. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu. Rev. Physiol. 2010, 72:463-493.
5. Wolburg H., Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul. Pharmacol. 2002, 38:323-337.
6. Gloor S.M., Wachtel M., Bolliger M.F., Ishihara H., Landmann R., Frei K. Molecular and cellular permeability control at the blood-brain barrier. Brain Res. Rev. 2001, 36:258-264.
7. Nag S., Venugopalan R., Stewart D.J. Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown. Acta Neuropathol. 2007, 114(5):459-469.
8. Zhong Y., Smart E.J., Weksler B., Couraud P.O., Hennig B., Toborek M. Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling. J Neurosci. 2008, 28(31):7788-7796.
9. + influx increases respiration and enhances ROS production while maintaining membrane potential. Am. J. Physiol. Cell Physiol. 2007, 292(1):C148-C156.
10. Pun P.B., Lu J., Moochhala S. Involvement of ROS in BBB dysfunction. Free Radic. Res. 2009, 43(4):348-364.
11. Schreibelt G., Kooij G., Reijerkerk A., van Doorn R., Gringhuis S.I., van der Pol S., Weksler B.B., Romero I.A., Couraud P.O., Piontek J., Blasig I.E., Dijkstra C.D., Ronken E., de Vries H.E. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J. 2007, 21(13):3666-3676.
12. Tsutsumi Y.M., Yokoyama T., Horikawa Y., Roth D.M., Patel H.H. Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization. Life Sci. 2007, 81(September (15)):1223-1227.
13. Aoki T., Sumii T., Mori T., Wang X., Lo E.H. Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats. Stroke 2002, 33(11):2711-2717.
14. Xie H., Xue Y.X., Liu L.B., Liu Y.H. Endothelial-monocyte-activating polypeptide II increases blood-tumor barrier permeability by down-regulating the expression levels of tight junction associated proteins. Brain Res. 2010, 319(March):13-20.
15. Vermeulen N.P.E., Baldew G.S. The role of lipid peroxidation in the nephrotoxicity of cisplatin. Biochem. Pharmacol. 1992, l 44:1193-1199.
16. Huber J.D., Egleton R.D., Davis T.P. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 2001, 24:719-725.
17. Harhaj N.S., Antonetti D.A. Regulation of tight junctions and loss of barrier function in pathophysiology. Int. J. Biochem. Cell Biol. 2004, 36:1206-1237.
18. Fischer S., Wobben M., Marti H.H., Renz D., Schaper W. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc. Res. 2002, 63:70-80.
19. Hawkins B.T., Abbruscato T.J., Egleton R.D., Brown R.C., Huber J.D., Campos C.R., Davis T.P. Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res. 2004, 1027:48-58.
20. Bamforth S.D., Kniesel U., Wolburg H., Engelhardt B., Risau W. A dominant mutant of occludin disrupts tight junction structure and function. J. Cell Sci. 1999, 112:1879-1888.
21. Kicinska A., Szewczyk A. Large-conductance potassium cation channel opener NS1619 inhibits cardiac mitochondria respiratory chain. Toxicol. Mech. Methods 2004, 14(1-2):59-61.
22. + influx increases respiration and enhances ROS production while maintaining membrane potential. Am. J Physiol. Cell. Physiol. 2007, 292:C148-C156.